Detalhe da pesquisa
1.
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
N Engl J Med
; 384(9): 795-807, 2021 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33306283
2.
Risk factors for resistant gram-positive bacteremia in febrile neutropenic patients with cancer.
J Infect Chemother
; 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38518846
3.
A Double-Blind, Randomized, Placebo-Controlled, Phase II Clinical Study To Evaluate the Efficacy and Safety of Camostat Mesylate (DWJ1248) in Adult Patients with Mild to Moderate COVID-19.
Antimicrob Agents Chemother
; 67(1): e0045222, 2023 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36515544
4.
Remdesivir for the Treatment of Covid-19 - Final Report.
N Engl J Med
; 383(19): 1813-1826, 2020 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32445440
5.
Comparable humoral and cellular immunity against Omicron variant BA.4/5 of once-boosted BA.1/2 convalescents and twice-boosted COVID-19-naïve individuals.
J Med Virol
; 95(2): e28558, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36755360
6.
Tracking antigen-specific TCR clonotypes in SARS-CoV-2 infection reveals distinct severity trajectories.
J Med Virol
; 95(11): e29199, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37916645
7.
Incidence, Severity, and Mortality of Influenza During 2010-2020 in Korea: A Nationwide Study Based on the Population-Based National Health Insurance Service Database.
J Korean Med Sci
; 38(8): e58, 2023 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36852854
8.
Effect of Wearing Personal Protective Equipment (PPE) for COVID-19 Treatment on Blood Culture Contamination: Implication for Optimal PPE Strategies.
J Korean Med Sci
; 38(23): e180, 2023 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37309699
9.
Risk Factors for the Prescription of Ineffective Antiviral Candidates for COVID-19 During the Early Pandemic Period in Korea.
J Korean Med Sci
; 38(36): e280, 2023 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37698205
10.
Persistent Antibody Responses Up to 18 Months After Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
J Infect Dis
; 226(7): 1224-1230, 2022 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35299253
11.
Comparison of Complications after Coronavirus Disease and Seasonal Influenza, South Korea.
Emerg Infect Dis
; 28(2): 347-353, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35076368
12.
Evaluation of Seropositivity After Standard Doses of Vaccination Against SARS-CoV-2 in Patients With Early Breast Cancer Receiving Adjuvant Treatment.
Oncologist
; 27(12): e931-e937, 2022 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36218350
13.
Accurate Diagnosis of COVID-19 from Self-Collectable Biospecimens Using Synthetic Apolipoprotein H Peptide-Coated Nanoparticle Assay.
Anal Chem
; 94(49): 17186-17194, 2022 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36399654
14.
Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection.
BMC Med
; 20(1): 181, 2022 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35508998
15.
Beneficial Effect of Statins in COVID-19-Related Outcomes-Brief Report: A National Population-Based Cohort Study.
Arterioscler Thromb Vasc Biol
; 41(3): e175-e182, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33535790
16.
How We Have Treated Severe to Critically Ill Patients With Coronavirus Disease 2019 in Korea.
J Korean Med Sci
; 37(49): e353, 2022 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36536547
17.
Clinical Impact of Empirical Antibiotic Therapy in Patients With Coronavirus Disease 2019 Requiring Oxygen Therapy.
J Korean Med Sci
; 37(29): e238, 2022 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35880508
18.
Kinetics of Neutralizing Antibody Responses Against SARS-CoV-2 Delta Variant in Patients Infected at the Beginning of the Pandemic.
J Korean Med Sci
; 37(8): e67, 2022 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35226425
19.
Changes in Anxiety Level and Personal Protective Equipment Use Among Healthcare Workers Exposed to COVID-19.
J Korean Med Sci
; 37(16): e126, 2022 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35470600
20.
Booster BNT162b2 COVID-19 Vaccination Increases Neutralizing Antibody Titers Against the SARS-CoV-2 Omicron Variant in Both Young and Elderly Adults.
J Korean Med Sci
; 37(9): e70, 2022 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35257525